The sooner examine (31) (N=56 patients) located higher levels of retrospectively assessed acute pressure disorder symptoms and present PTSD indicators between patients who been given enantiomer esketamine, compared with individuals that gained racemic ketamine or opioids; the racemic ketamine group also showed mildly elevated acute anxiety disorder